Published in J Magn Reson Imaging on August 23, 2012
Towards coronary plaque imaging using simultaneous PET-MR: a simulation study. Phys Med Biol (2014) 0.82
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation (1983) 12.63
Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation (1999) 11.04
An improved MR imaging technique for the visualization of myocardial infarction. Radiology (2001) 7.45
Simple proton spectroscopic imaging. Radiology (1984) 7.30
Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction. Magn Reson Med (1991) 5.06
Multicoil Dixon chemical species separation with an iterative least-squares estimation method. Magn Reson Med (2004) 4.88
Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL): application with fast spin-echo imaging. Magn Reson Med (2005) 4.57
The association of pericardial fat with calcified coronary plaque. Obesity (Silver Spring) (2008) 2.93
Field map estimation with a region growing scheme for iterative 3-point water-fat decomposition. Magn Reson Med (2005) 2.82
Coronary angiography with magnetization-prepared T2 contrast. Magn Reson Med (1995) 2.79
Respiratory motion of the heart: kinematics and the implications for the spatial resolution in coronary imaging. Magn Reson Med (1995) 2.69
Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur Heart J (2007) 2.60
Fat suppression in MR imaging: techniques and pitfalls. Radiographics (1999) 2.56
Dixon techniques for water and fat imaging. J Magn Reson Imaging (2008) 2.47
Breath-hold water and fat imaging using a dual-echo two-point Dixon technique with an efficient and robust phase-correction algorithm. Magn Reson Med (2004) 2.46
Joint estimation of water/fat images and field inhomogeneity map. Magn Reson Med (2008) 2.35
Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis. Arterioscler Thromb Vasc Biol (2009) 2.33
Pericardial fat is independently associated with human atrial fibrillation. J Am Coll Cardiol (2010) 2.26
Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria. JACC Cardiovasc Imaging (2011) 2.22
Robust water/fat separation in the presence of large field inhomogeneities using a graph cut algorithm. Magn Reson Med (2010) 2.13
Improved coronary artery definition with T2-weighted, free-breathing, three-dimensional coronary MRA. Circulation (1999) 2.02
Whole-heart coronary magnetic resonance angiography at 3 Tesla in 5 minutes with slow infusion of Gd-BOPTA, a high-relaxivity clinical contrast agent. Magn Reson Med (2007) 1.94
Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study. Am Heart J (2007) 1.86
Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol (1996) 1.74
Dual-echo Dixon imaging with flexible choice of echo times. Magn Reson Med (2011) 1.71
Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0-T: a comparative study with X-ray angiography in a single center. J Am Coll Cardiol (2009) 1.61
B1-insensitive T2 preparation for improved coronary magnetic resonance angiography at 3 T. Magn Reson Med (2006) 1.58
Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol (2006) 1.55
Relationship between motion of coronary arteries and diaphragm during free breathing: lessons from real-time MR imaging. AJR Am J Roentgenol (1999) 1.53
Multiecho dixon fat and water separation method for detecting fibrofatty infiltration in the myocardium. Magn Reson Med (2009) 1.50
Phase unwrapping in the three-point Dixon method for fat suppression MR imaging. Radiology (1994) 1.20
Adipose tissue in myocardial infarction. Cardiovasc Pathol (2004) 1.10
Epicardial fat: an additional measurement for subclinical atherosclerosis and cardiovascular risk stratification? J Am Soc Echocardiogr (2010) 1.09
Myocardial Fat Imaging. Curr Cardiovasc Imaging Rep (2010) 1.05
The association of pericardial fat with coronary artery plaque index at MR imaging: The Multi-Ethnic Study of Atherosclerosis (MESA). Radiology (2011) 0.96
Arrhythmogenic right ventricular dysplasia: ex vivo and in vivo fat detection with black-blood MR imaging. Radiology (2004) 0.95
Fat-water separated delayed hyperenhanced myocardial infarct imaging. Magn Reson Med (2008) 0.94
Contrast-enhanced whole-heart coronary MRI with bolus infusion of gadobenate dimeglumine at 1.5 T. Magn Reson Med (2010) 0.94
Myocardial fat deposition after left ventricular myocardial infarction: assessment by using MR water-fat separation imaging. Radiology (2009) 0.89
Effect of epicardial fat on electroanatomical mapping and epicardial catheter ablation. J Am Coll Cardiol (2010) 0.86
Fat deposition in the myocardium of the left ventricle. J Cardiovasc Magn Reson (2007) 0.76
Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med (2004) 6.27
Evidence for human lung stem cells. N Engl J Med (2011) 5.67
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA (2012) 5.27
American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr (2004) 4.88
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol (2008) 4.51
Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med (2008) 4.50
Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters. J Magn Reson Imaging (2007) 4.18
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 4.01
Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med (2007) 3.88
Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging (2007) 3.79
Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation (2008) 3.77
Compressed sensing in dynamic MRI. Magn Reson Med (2008) 3.65
Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation (2003) 3.20
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J (2004) 3.19
Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 3.11
Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology (2011) 3.08
Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology (2007) 2.93
Field map estimation with a region growing scheme for iterative 3-point water-fat decomposition. Magn Reson Med (2005) 2.82
Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol (2008) 2.82
Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging (2012) 2.76
Cramér-Rao bounds for three-point decomposition of water and fat. Magn Reson Med (2005) 2.63
Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy. Circ Cardiovasc Imaging (2011) 2.54
Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. Am Heart J (2012) 2.42
k-t PCA: temporally constrained k-t BLAST reconstruction using principal component analysis. Magn Reson Med (2009) 2.41
Cardiac SSFP imaging at 3 Tesla. Magn Reson Med (2004) 2.33
Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort. J Am Coll Cardiol (2002) 2.33
Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement: a pilot study. JACC Cardiovasc Imaging (2009) 2.33
T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging (2011) 2.27
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 2.23
Dynamic contrast-enhanced myocardial perfusion MRI accelerated with k-t sense. Magn Reson Med (2007) 2.18
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 2.14
"Soap-Bubble" visualization and quantitative analysis of 3D coronary magnetic resonance angiograms. Magn Reson Med (2002) 2.09
Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation (2011) 2.04
4D flow MRI. J Magn Reson Imaging (2012) 2.02
Effects of refocusing flip angle modulation and view ordering in 3D fast spin echo. Magn Reson Med (2008) 1.96
Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging (2012) 1.90
Cardiovascular magnetic resonance characterization of mitral valve prolapse. JACC Cardiovasc Imaging (2008) 1.87
Validation of dynamic 3-dimensional whole heart magnetic resonance myocardial perfusion imaging against fractional flow reserve for the detection of significant coronary artery disease. J Am Coll Cardiol (2012) 1.86
Influence of multichannel combination, parallel imaging and other reconstruction techniques on MRI noise characteristics. Magn Reson Imaging (2008) 1.82
Preliminary report on in vivo coronary MRA at 3 Tesla in humans. Magn Reson Med (2002) 1.82
Array compression for MRI with large coil arrays. Magn Reson Med (2007) 1.81
T1 independent, T2* corrected MRI with accurate spectral modeling for quantification of fat: validation in a fat-water-SPIO phantom. J Magn Reson Imaging (2009) 1.71
Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation (2006) 1.69
First evidence of depressed contractility in the border zone of a human myocardial infarction. Ann Thorac Surg (2012) 1.68
Nkx2.5 homeoprotein regulates expression of gap junction protein connexin 43 and sarcomere organization in postnatal cardiomyocytes. J Mol Cell Cardiol (2003) 1.67
Prevalence of non-cardiac pathology on clinical transthoracic echocardiography. J Am Soc Echocardiogr (2012) 1.67
Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction. Magn Reson Med (2011) 1.67
Correlation of trabeculae and papillary muscles with clinical and cardiac characteristics and impact on CMR measures of LV anatomy and function. JACC Cardiovasc Imaging (2012) 1.66
Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy. Circulation (2009) 1.66
Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation (2009) 1.65
Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function. Circulation (2013) 1.64
Fat and water magnetic resonance imaging. J Magn Reson Imaging (2010) 1.64
Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy. J Am Coll Cardiol (2013) 1.60
Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail (2008) 1.58
Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation (2010) 1.57
ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. J Am Coll Cardiol (2005) 1.56
Clinical feasibility of accelerated, high spatial resolution myocardial perfusion imaging. JACC Cardiovasc Imaging (2010) 1.56
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. J Cardiovasc Magn Reson (2004) 1.54
Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson (2006) 1.54
In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation (2004) 1.53
Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice. Radiology (2010) 1.53
Accelerating cine phase-contrast flow measurements using k-t BLAST and k-t SENSE. Magn Reson Med (2005) 1.50
Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology (2007) 1.49
Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol (2009) 1.48
C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation (2002) 1.46
CMR predictors of mitral regurgitation in mitral valve prolapse. JACC Cardiovasc Imaging (2010) 1.45
In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation (2004) 1.45
Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation (2002) 1.44
Right Ventricular Volumes and Systolic Function by Cardiac Magnetic Resonance and the Impact of Sex, Age, and Obesity in a Longitudinally Followed Cohort Free of Pulmonary and Cardiovascular Disease: The Framingham Heart Study. Circ Cardiovasc Imaging (2016) 1.42
Low-dimensional-structure self-learning and thresholding: regularization beyond compressed sensing for MRI reconstruction. Magn Reson Med (2011) 1.41
Cardiac MRI of ischemic heart disease at 3 T: potential and challenges. Eur J Radiol (2008) 1.40
ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance. Circulation (2005) 1.40
Facility perception of nuclear cardiology accreditation: Results of an Intersocietal Accreditation Commission (IAC) survey. J Nucl Cardiol (2014) 1.39
Side-to-side arteriovenous fistula at the elbow with perforating vein ligation. J Vasc Surg (2008) 1.39
Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol (2009) 1.39
Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation (2006) 1.38
Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study. Arterioscler Thromb Vasc Biol (2002) 1.38
MRI temporal acceleration techniques. J Magn Reson Imaging (2012) 1.37
Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am (2010) 1.37
Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia. Circulation (2010) 1.37
Diffusion imaging of the in vivo heart using spin echoes--considerations on bulk motion sensitivity. Magn Reson Med (2007) 1.36
Right ventricular involvement in hypertrophic cardiomyopathy. Am J Cardiol (2007) 1.35
Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct. Am J Cardiol (2010) 1.34
Generalized k-space decomposition with chemical shift correction for non-Cartesian water-fat imaging. Magn Reson Med (2008) 1.34
Computed tomography and magnetic resonance imaging of the pericardium: anatomy and pathology. Magn Reson Med Sci (2004) 1.33
Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction. JACC Cardiovasc Imaging (2009) 1.32
Accelerated whole-heart 3D CSPAMM for myocardial motion quantification. Magn Reson Med (2008) 1.31
Prospective self-gating for simultaneous compensation of cardiac and respiratory motion. Magn Reson Med (2008) 1.31
Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol (2008) 1.31
Magnetic resonance--guided coronary artery stent placement in a swine model. Circulation (2002) 1.30
k-t BLAST reconstruction from non-Cartesian k-t space sampling. Magn Reson Med (2006) 1.28